Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 10/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.78 |
| ▸ | GAA | P10253 | 10/20 | 0.65 |
| ▸ | NPC1 | O15118 | 9/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.65 |
| ▸ | MAPT | P10636 | 3/20 | 0.63 |
| ▸ | PKM | P14618 | 3/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | AGTR1 | P30556 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12720841 | 0.93 | RAB9A (0.88) | RAB9ASMN1; SMN2GAANPC1KMT2A | |
| SCHEMBL30873792 | 0.87 | RAB9A (0.72) | RAB9ASMN1; SMN2GAANPC1KMT2A | |
| SCHEMBL12720817 | 0.85 | NPC1 (0.76) | RAB9ASMN1; SMN2GAANPC1KMT2A | |
| SCHEMBL12720802 | 0.81 | AGTR1 (0.71) | RAB9ASMN1; SMN2GAANPC1KMT2A | |
| SCHEMBL12720839 | 0.81 | NPC1 (0.70) | RAB9ASMN1; SMN2GAANPC1KMT2A | |
| SCHEMBL24835694 | 0.78 | RAB9A (0.60) | RAB9ASMN1; SMN2GAANPC1KMT2A | |
| SCHEMBL30777268 | 0.78 | RAB9A (0.60) | RAB9ASMN1; SMN2GAANPC1KMT2A | |
| SCHEMBL3188677 | 0.78 | ALDH1A1 (0.62) | RAB9ASMN1; SMN2GAANPC1KMT2A | |
| SCHEMBL4508472 | 0.77 | CES2 (0.64) | RAB9ASMN1; SMN2GAANPC1KMT2A | |
| SCHEMBL12720823 | 0.76 | AGTR1 (0.88) | RAB9ASMN1; SMN2GAANPC1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7928049-B2 | Use of metal complex compounds as oxidation catalysts | BASF SE Ludwigshafen (DE) | 2011-04-19 | — | — | US | disclosed |
| US-7928049-B2 | Use of metal complex compounds as oxidation catalysts | BASF SE Ludwigshafen (DE) | 2011-04-19 | — | — | US | disclosed |
| US-20110021407-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA CORPORATION (US) | 2011-01-27 | — | — | US | disclosed |
| US-20110021407-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | CIBA CORPORATION (US) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021407-A1 | USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS | SOD1, MPO, LPO | RAB9A 4379/4885SMN1; SMN2 3007/4885GAA 185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.